Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2013; 19(8): 1210-1218
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1210
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1210
Figure 5 Effects of Mitogen-activated protein kinases inhibitors on lipopolysaccharide-induced action in interstitial cells of Cajal.
A: Pacemaker currents of interstitial cells of Cajal (ICCs) incubated at 37 °C with 200 μg/mL of lipopolysaccharide (LPS) for 12 h at a holding potential of -70 mV; B: Pacemaker currents after pretreatment with PD 98059 (10 μmol/L) for 2 h prior to LPS incubation; C: Pacemaker currents after pretreatment with SB 203580 (10 μmol/L) for 2 h prior to LPS incubation; D: Pacemaker currents after pretreatment with c-Jun N-terminal kinase (JNK) inhibitor II (10 μmol/L) for 2 h prior to LPS incubation. The effects of mitogen-activated protein kinases inhibitors on the LPS-induced action are summarized in E and F. Bars represent mean ± SE values (n = 7 per group). aP < 0.05 vs LPS.
-
Citation: Zuo DC, Choi S, Shahi PK, Kim MY, Park CG, Kim YD, Lee J, Chang IY, So I, Jun JY. Inhibition of pacemaker activity in interstitial cells of Cajal by LPS
via NF-κB and MAP kinase. World J Gastroenterol 2013; 19(8): 1210-1218 - URL: https://www.wjgnet.com/1007-9327/full/v19/i8/1210.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i8.1210